Condition: Head and Neck Neoplasms
Intervention: Drug: SCB01A
Sponsor: SynCore Biotechnology Co., Ltd.
Not yet recruiting - verified January 2017
IJMS, Vol. 18, Pages 477: Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer - Chromatin remodeling alters gene expression in carcinoma tissue. Although cervical cancer is the fourth most common cancer in women worldwide, a systematic...